ADAR1 Capital Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
62,088
-91,679
| -60% | -$2.12M | 0.22% | 66 |
|
|
2025
Q1 | $4.15M | Buy |
153,767
+122,258
| +388% | +$3.3M | 0.77% | 35 |
|
|
2024
Q4 | $1.69M | Buy |
31,509
+18,509
| +142% | +$991K | 0.34% | 54 |
|
|
2024
Q3 | $591K | Buy |
13,000
+5,109
| +65% | +$232K | 0.1% | 97 |
|
|
2024
Q2 | $331K | Sell |
7,891
-6,109
| -44% | -$256K | 0.06% | 113 |
|
|
2024
Q1 | $527K | Buy |
+14,000
| New | +$527K | 0.12% | 74 |
|